Origin & tradition
NMN is not a traditional remedy but a modern molecule at the center of the NAD+ longevity field studied at Harvard and Washington University. NAD+, the coenzyme it feeds, declines with age.
Western tradition · NAD+ precursor · Longevity supplement
NMN (Nicotinamide Mononucleotide) β-烟酰胺单核苷酸
The headline NAD+ booster of the longevity world — human trials show it raises blood NAD+ and may support physical function.
Why longevity buyers care
Key active: Nicotinamide mononucleotide (NAD+ precursor).
NMN is a direct precursor to NAD+, the coenzyme that fuels mitochondrial energy and sirtuin activity and declines with age. A 2022 randomized, placebo-controlled trial in healthy middle-aged adults found dose-dependent increases in blood NAD+ and improved six-minute walking distance.
Evidence summary
What the research actually says
79Evidence confidence
Human RCTs on NAD+ levels & physical function; long-term longevity outcomes still open
NMN is a direct precursor to NAD+, the coenzyme that fuels mitochondrial energy and sirtuin activity and declines with age. A 2022 randomized, placebo-controlled trial in healthy middle-aged adults found dose-dependent increases in blood NAD+ and improved six-minute walking distance.
31registered clinical trials reference this intervention
2selected from 30+ PubMed papers (longevity / aging angle)
Key active: Nicotinamide mononucleotide (NAD+ precursor).
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-06-05. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Compare the evidence
How NMN (Nicotinamide Mononucleotide) stacks up
Verified suppliers
No verified NMN (Nicotinamide Mononucleotide) suppliers listed yet
Tell us what you need and we will source verified suppliers for you.